The four-year agreement will support the team’s ongoing work on removing PFAS from soil. Photo via Rice University

A Rice University chemist James Tour has secured a new $12 million cooperative agreement with the U.S. Army Engineer Research and Development Center on the team’s work to efficiently remove pollutants from soil.

The four-year agreement will support the team’s ongoing work on removing per- and polyfluoroalkyl substances (PFAS) from contaminated soil through its rapid electrothermal mineralization (REM) process, according to a statement from Rice.

Traditionally PFAS have been difficult to remove by conventional methods. However, Tour and the team of researchers have been developing this REM process, which heats contaminated soil to 1,000 C in seconds and converts it into nontoxic calcium fluoride efficiently while also preserving essential soil properties.

“This is a substantial improvement over previous methods, which often suffer from high energy and water consumption, limited efficiency and often require the soil to be removed,” Tour said in the statement.

The funding will help Tour and the team scale the innovative REM process to treat large volumes of soil. The team also plans to use the process to perform urban mining of electronic and industrial waste and further develop a “flash-within-flash” heating technology to synthesize materials in bulk, according to Rice.

“This research advances scientific understanding but also provides practical solutions to critical environmental challenges, promising a cleaner, safer world,” Christopher Griggs, a senior research physical scientist at the ERDC, said in the statement.

Also this month, Tour and his research team published a report in Nature Communications detailing another innovative heating technique that can remove purified active materials from lithium-ion battery waste, which can lead to a cleaner production of electric vehicles, according to Rice.

“With the surge in battery use, particularly in EVs, the need for developing sustainable recycling methods is pressing,” Tour said in a statement.

Similar to the REM process, this technique known as flash Joule heating (FJH) heats waste to 2,500 Kelvin within seconds, which allows for efficient purification through magnetic separation.

This research was also supported by the U.S. Army Corps of Engineers, as well as the Air Force Office of Scientific Research and Rice Academy Fellowship.

Last year, a fellow Rice research team earned a grant related to soil in the energy transition. Mark Torres, an assistant professor of Earth, environmental and planetary sciences; and Evan Ramos, a postdoctoral fellow in the Torres lab; were given a three-year grant from the Department of Energy to investigate the processes that allow soil to store roughly three times as much carbon as organic matter compared to Earth's atmosphere.

By analyzing samples from the East River Watershed, the team aims to understand if "Earth’s natural mechanisms of sequestering carbon to combat climate change," Torres said in a statement.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.